Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

OTHER 17 OTHER_GOV 2 INDUSTRY 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Genetic Diseases, Inborn 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 42 Docetaxel 33 Paclitaxel 31 Tamoxifen 29 Doxorubicin 29 Trastuzumab 25 Radiotherapy 21 Epirubicin 16 Letrozole 15 Anastrozole 12 exemestane 11 Fluorouracil 11 Capecitabine 10 Bevacizumab 10 palbociclib 9 Immunohistochemistry 9 Fulvestrant 9 Filgrastim 9 Lapatinib 8 Zoledronic Acid 7 Methotrexate 7 Magnetic Resonance Spectroscopy 7 Gene Expression Profiling 7 pertuzumab 6 Triptorelin Pamoate 6 Taxes 6 Surgical Procedures, Operative 6 Microarray Analysis 6 Goserelin 6 Chemotherapy, Adjuvant 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Tablets × Breast × Clear all

NCT05392608 2026-05-22

SEQUEL-Breast

Borstkanker Onderzoek Groep

Phase 2 Active not recruiting

Breast Neoplasms, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon ⚡